We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Mouse Allergen and Asthma Intervention Trial (MAAIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01251224
Recruitment Status : Completed
First Posted : December 1, 2010
Last Update Posted : March 16, 2017
Boston Children’s Hospital
Columbia University
Information provided by (Responsible Party):
Elizabeth Matsui, Johns Hopkins University

Brief Summary:
The MAAIT is a randomized, controlled trial of a home intervention to reduce mouse allergen exposure in mouse allergic children with asthma and mouse allergen exposure. Participants will be randomized to either the Integrated Pest Management (IPM) Group or the Education Group. The IPM Group will receive professional mouse abatement, education, two HEPA filters, allergen-proof mattress and pillow encasements, and targeted cleaning. The Education Group will receive education about IPM at the beginning of the trial and then after completion of the trial, will receive the IPM intervention. Participants will be followed for 12 months.

Condition or disease Intervention/treatment Phase
Asthma Mouse Allergy Mouse Allergen Exposure Other: Integrated Pest Management Other: Education Phase 3

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 361 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Mouse Allergen and Asthma Intervention Trial
Study Start Date : November 2010
Primary Completion Date : September 2016
Study Completion Date : September 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma
U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: Education Group
This group will receive IPM education at baseline, and then the full IPM intervention after completing the study.
Other: Education
This group will receive education about mouse IPM.
Experimental: IPM Group
This group will receive the full IPM intervention at baseline.
Other: Integrated Pest Management
The IPM intervention will include professional mouse abatement, two HEPA filters, targeted cleaning, education about IPM, and allergen-proof mattress and pillow encasements. The intervention will be delivered at baseline to the IPM Group, and then repeated if recurrent or persistent mouse infestation is present.

Primary Outcome Measures :
  1. change in asthma symptoms [ Time Frame: 0, 3, 6, 9, 12 months ]
    days of asthma symptoms

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   6 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • persistent asthma
  • exacerbation, previous 12 months
  • evidence of mouse sensitization
  • high levels of mouse allergen in home
  • ages 5-17 years

Exclusion Criteria:

  • intermittent asthma
  • no exacerbation in previous 12 months
  • not sensitized to mouse
  • low or undetectable mouse allergen in home
  • other lung disease aside from asthma

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01251224

United States, Maryland
Johns Hopkins
Baltimore, Maryland, United States, 21287
United States, Massachusetts
Boston Children's
Boston, Massachusetts, United States, 02210
Sponsors and Collaborators
Johns Hopkins University
Boston Children’s Hospital
Columbia University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Elizabeth Matsui, Associate Professor, Johns Hopkins University
ClinicalTrials.gov Identifier: NCT01251224     History of Changes
Other Study ID Numbers: 1U01AI083238 ( U.S. NIH Grant/Contract )
First Posted: December 1, 2010    Key Record Dates
Last Update Posted: March 16, 2017
Last Verified: March 2017

Keywords provided by Elizabeth Matsui, Johns Hopkins University:
mouse allergen
environmental intervention

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases